Chemotherapy and bevacizumab (CT-BEV)

DRUG2 trials

Sponsors

Hospices Civils de Lyon, N.N. Alexandrov National Cancer Centre

Conditions

Metastatic Cervical CancerOvarian Epithelial CancerPersistent Cervical CancerRecurrent Cervical Cancer

Phase 2

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

RecruitingNCT07472153

N.N. Alexandrov National Cancer CentreMetastatic Cervical Cancer, Persistent Cervical Cancer, Recurrent Cervical Cancer

Start: 2025-07-01End: 2033-06-30Target: 120Updated: 2026-03-16

Phase 3

Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

Hospices Civils de LyonOvarian Epithelial Cancer

Start: 2019-11-30End: 2022-11-30Target: 132Updated: 2019-11-01